Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia

Summary

RATIONALE: Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying the side effects of azacitidine and to see how well it works in treating patients with chronic myelomonocytic leukemia.

Timeline

Start

2010-01

Primary completion

2012-12

Completion

2013-05

Drugs

Indications